MENU
FATE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Fate Therapeutics (FATE) Ownership - Who owns Fate Therapeutics?

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
12278 Scripps Summit Drive
Phone
+1 858 875-1800
Employees
161
Web
https://www.fatetherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
276.79M
P/E Ratio
N/A
Total Cash
153.77M
Projected Growth
N/A
Total Debt
75.68M
Revenue
6.49M
Risk (Beta)
3.75
Dividend Yield
N/A
Total Cash/Share
1.28
Total Debt/Equity
2.75
Revenue/Share
0.05 USD as % of share price
View a ticker or compare two or three
FATE
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
12278 Scripps Summit Drive
Phone
+1 858 875-1800
Employees
161
Web
https://www.fatetherapeutics.com
Who owns Fate Therapeutics? FATE symbol Ownership - Tickeron.com